JPMORGAN CHASE & CO - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 105 filers reported holding ALBIREO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$233
-99.9%
10,781
+13.5%
0.00%
Q3 2022$183,000
-1.6%
9,498
+2.0%
0.00%
Q2 2022$186,000
-22.2%
9,308
+16.2%
0.00%
Q1 2022$239,000
+53.2%
8,010
+20.1%
0.00%
Q4 2021$156,000
-21.6%
6,669
+4.7%
0.00%
Q3 2021$199,000
-14.2%
6,367
-3.1%
0.00%
Q2 2021$232,000
+2.7%
6,569
+2.4%
0.00%
Q1 2021$226,000
-19.9%
6,415
-14.8%
0.00%
Q4 2020$282,000
+74.1%
7,533
+51.9%
0.00%
Q3 2020$162,000
+36.1%
4,958
+10.3%
0.00%
Q2 2020$119,000
-49.4%
4,497
-68.8%
0.00%
Q1 2020$235,000
+1.7%
14,424
+58.7%
0.00%
Q4 2019$231,000
+225.4%
9,091
+154.9%
0.00%
Q3 2019$71,000
-21.1%
3,567
+25.8%
0.00%
Q2 2019$90,000
+25.0%
2,836
+27.6%
0.00%
Q1 2019$72,000
+26.3%
2,222
-4.5%
0.00%
Q4 2018$57,000
-18.6%
2,326
+10.2%
0.00%
Q3 2018$70,000
-36.9%
2,110
-32.2%
0.00%
Q2 2018$111,000
+2675.0%
3,111
+1455.5%
0.00%
Q3 2017$4,0002000.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Prosight Management, LP 514,082$11,973,0007.17%
Privium Fund Management B.V. 379,117$8,959,0001.78%
Birchview Capital, LP 113,000$2,632,0001.70%
Sio Capital Management, LLC 213,913$4,982,0001.50%
Perceptive Advisors 4,720,278$109,936,0000.85%
Chicago Capital, LLC 849,239$19,779,0000.74%
APOGEM CAPITAL LLC 38,601$899,0000.59%
Samsara BioCapital, LLC 100,000$2,329,0000.45%
Artal Group S.A. 600,000$13,974,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 458,011$10,667,0000.38%
View complete list of ALBIREO PHARMA INC shareholders